1. Home
  2. LULU vs NBIX Comparison

LULU vs NBIX Comparison

Compare LULU & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo lululemon athletica inc.

LULU

lululemon athletica inc.

HOLD

Current Price

$132.66

Market Cap

16.5B

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$148.83

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LULU
NBIX
Founded
1998
1992
Country
Canada
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.5B
13.2B
IPO Year
2007
1996

Fundamental Metrics

Financial Performance
Metric
LULU
NBIX
Price
$132.66
$148.83
Analyst Decision
Hold
Strong Buy
Analyst Count
25
22
Target Price
$190.26
$180.91
AVG Volume (30 Days)
2.8M
1.1M
Earning Date
06-04-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
41.95
EPS
13.26
1.91
Revenue
$11,102,600,000.00
$161,626,000.00
Revenue This Year
$5.52
$24.73
Revenue Next Year
$4.68
$13.14
P/E Ratio
$9.98
$77.03
Revenue Growth
4.86
977.51
52 Week Low
$127.80
$115.66
52 Week High
$340.25
$160.18

Technical Indicators

Market Signals
Indicator
LULU
NBIX
Relative Strength Index (RSI) 31.58 75.91
Support Level N/A $133.96
Resistance Level $170.94 $148.99
Average True Range (ATR) 4.78 3.58
MACD -1.79 1.95
Stochastic Oscillator 11.23 97.46

Price Performance

Historical Comparison
LULU
NBIX

About LULU lululemon athletica inc.

Lululemon Athletica designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. The company offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. Lululemon also sells fitness accessories, such as bags, yoga mats, and equipment. It sells its products through digital channels, a small number of wholesale partners, more than 800 company-owned stores in about two dozen countries in North America, Asia, and Western Europe, and about 45 franchised locations in the Middle East and Europe. The company was founded in 1998 and is based in Vancouver, Canada.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: